PubMedMini reviews in medicinal chemistry2026-11-13
Pharmacological Significance of Imidazole-coumarin Hybrids: Current Perspectives.
Bhyan Puneet P, Rohilla Sonia S, Verma Vikas V, Singh Vikramjeet V et al.
Imidazole and coumarin are privileged heterocyclic scaffolds with broad pharmacological relevance and established clinical applications, exemplified by imidazole-based antifungals such as Miconazole, Clotrimazole, and Ketoconazole, and the coumarin-derived anticoagulant warfarin. Their complementary pharmacophoric features have stimulated the development of imidazolecoumarin hybrids as multifunctional candidates with potentially improved biological profiles. This review critically summarizes recent advances in the synthesis, biological evaluation, Structure- Activity Relationships (SAR), and mechanisms of imidazole-coumarin hybrids. Reported synthetic approaches for these hybrids are briefly outlined, while emphasis is placed on their antibacterial, antifungal, anticancer, antiviral, antioxidant, antitubercular, and antihelminthic activities. Particular attention is given to the influence of substituent type and position on the coumarin and imidazole/ benzimidazole nuclei, as well as linker characteristics, on biological activity. The review further distinguishes experimentally supported molecular mechanisms, including enzyme or target interactions, membrane-related effects, oxidative stress modulation, and apoptosis-associated pathways, from activities established only by phenotypic screening. Available potency data, including MIC and IC50 values, are critically compared where reported, while limited selectivity and ADMET information is highlighted as an important research gap. Finally, current challenges in mechanistic validation, in vivo efficacy, toxicity assessment, and rational SAR-guided optimization are discussed, providing directions for the development of more potent, selective, and pharmacokinetically suitable imidazole-coumarin hybrids.